Colgate India shares slide despite analyst optimism on premium growth

Colgate India's share price retreated 3% in trading, bucking analyst expectations for continued momentum in the company's premium product category. The decline comes despite renewed confidence from major investment houses regarding the company's business trajectory and margin expansion potential.

According to equity research from Jefferies, Colgate India's premium portfolio is gaining traction at a rate six times faster than its conventional offerings. This outperformance reflects a deliberate strategic pivot toward higher-value products, with the premium segment now commanding a revenue share 2.5 times larger than its proportion in 2021.

The shift toward premium products carries significant implications for Colgate India's profitability profile. Premium-positioned oral care products typically command higher gross margins, offering the company scope to improve overall profitability even as it invests in market expansion and brand building.

Investors appear to be weighing the long-term upside of Colgate India's premium strategy against near-term earnings volatility. While brokerages maintain constructive views on the company's fundamentals and growth prospects, the stock's recent weakness suggests market participants may be focusing on execution risks and competitive pressures in the near term.

The company's ability to sustain premium segment growth while defending market share in mass-market categories will be critical to validating analyst optimism in coming quarters.